LAMEA Viral Vector Production Market Size, Share & Trends Analysis Report By Type (Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others), By Indication, By Application, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Viral Vector Production Market would witness market growth of 23.4% CAGR during the forecast period (2023-2030).

Viral vectors are genetically modified viruses that deliver specific genes or genetic material into cells. They are extensively utilized in biotechnology and gene therapy to introduce therapeutic genes, correct genetic defects, or manipulate cellular processes. Several viral vectors, such as adenoviruses (ADV), adeno-associated viruses (AAV), lentiviruses, and retroviruses, are commonly used in biotechnology. Adenoviral vectors are derived from adenoviruses, which naturally infect humans and cause respiratory illnesses. In contrast, AAV vectors are derived from non-pathogenic viruses that depend on co-infection with helper viruses, such as adenoviruses, for replication. These viral vectors have wide applications in the biotechnology and pharmaceutical industries. They have revolutionized the fields of biotechnology and gene therapy, enabling the development of innovative treatments and tools for understanding and manipulating genetic processes.

The rise in the prevalence of cancer, infectious diseases, and genetic disorders has had a significant impact on the market. The increased burden of these diseases has created a growth in demand for innovative therapies, including gene therapy. There is a corresponding increase in the demand for viral vectors to support the development and manufacturing of gene therapies as the prevalence of these diseases continues to rise. This has driven the growth of the viral vector production market size. In addition, adopting strategies in the viral vector production market has contributed to its expansion. Companies implement various approaches to enhance efficiency, increase production capacity, and improve cost-effectiveness. Viral vector production companies can meet the rise in demand for viral vectors, streamline production processes, and reduce manufacturing costs, which is expected to support the market's growth.

The level of healthcare infrastructure development in the LAMEA region shapes the demand for advanced therapies. Investments in healthcare facilities may impact the adoption of gene therapies and, consequently, viral vector production. Economic stability may facilitate the growth of the viral vector production market. As a result, these aspects will boost market growth in the coming years.

The Brazil market dominated the LAMEA Viral Vector Production Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $85.5 Million by 2030. The Argentina market is showcasing a CAGR of 24% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 23% during (2023 - 2030).

Free Valuable Insights: The Worldwide Viral Vector Production Market is Projected to reach USD 3.9 Billion by 2030, at a CAGR of 19.1%

Based on Type, the market is segmented into Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others. Based on Indication, the market is segmented into Cancer, Genetic Disorders, Infectious Diseases, and Others. Based on Application, the market is segmented into Gene Therapy, and Vaccinology. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Andelyn Biosciences, Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• FinVector Oy (Ferring Ventures S/A)
• Thermo Fisher Scientific, Inc.
• Novartis AG
• Takara Bio Inc. (Takara Holdings Inc.)
• Avid Bioservices, Inc.
• Oxford Biomedica plc
• Lonza Group Ltd.

LAMEA Viral Vector Production Market Report Segmentation

By Type

• Adeno-Associated Viral Vectors
• Lentiviral Vectors
• Adenoviral Vectors
• Retroviral Vectors
• Others

By Indication

• Cancer
• Genetic Disorders
• Infectious Diseases
• Others

By Application

• Gene Therapy
• Vaccinology

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Viral Vector Production Market, by Type
1.4.2 LAMEA Viral Vector Production Market, by Indication
1.4.3 LAMEA Viral Vector Production Market, by Application
1.4.4 LAMEA Viral Vector Production Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in Viral Vector Production Market

Chapter 5. LAMEA Viral Vector Production Market, by Type
5.1 LAMEA Adeno-Associated Viral Vectors Market, by Country
5.2 LAMEA Lentiviral Vectors Market, by Country
5.3 LAMEA Adenoviral Vectors Market, by Country
5.4 LAMEA Retroviral Vectors Market, by Country
5.5 LAMEA Others Market, by Country

Chapter 6. LAMEA Viral Vector Production Market, by Indication
6.1 LAMEA Cancer Market, by Country
6.2 LAMEA Genetic Disorders Market, by Country
6.3 LAMEA Infectious Diseases Market, by Country
6.4 LAMEA Others Market, by Country

Chapter 7. LAMEA Viral Vector Production Market, by Application
7.1 LAMEA Gene Therapy Market, by Country
7.2 LAMEA Vaccinology Market, by Country

Chapter 8. LAMEA Viral Vector Production Market, by Country
8.1 Brazil Viral Vector Production Market
8.1.1 Brazil Viral Vector Production Market, by Type
8.1.2 Brazil Viral Vector Production Market, by Indication
8.1.3 Brazil Viral Vector Production Market, by Application
8.2 Argentina Viral Vector Production Market
8.2.1 Argentina Viral Vector Production Market, by Type
8.2.2 Argentina Viral Vector Production Market, by Indication
8.2.3 Argentina Viral Vector Production Market, by Application
8.3 UAE Viral Vector Production Market
8.3.1 UAE Viral Vector Production Market, by Type
8.3.2 UAE Viral Vector Production Market, by Indication
8.3.3 UAE Viral Vector Production Market, by Application
8.4 Saudi Arabia Viral Vector Production Market
8.4.1 Saudi Arabia Viral Vector Production Market, by Type
8.4.2 Saudi Arabia Viral Vector Production Market, by Indication
8.4.3 Saudi Arabia Viral Vector Production Market, by Application
8.5 South Africa Viral Vector Production Market
8.5.1 South Africa Viral Vector Production Market, by Type
8.5.2 South Africa Viral Vector Production Market, by Indication
8.5.3 South Africa Viral Vector Production Market, by Application
8.6 Nigeria Viral Vector Production Market
8.6.1 Nigeria Viral Vector Production Market, by Type
8.6.2 Nigeria Viral Vector Production Market, by Indication
8.6.3 Nigeria Viral Vector Production Market, by Application
8.7 Rest of LAMEA Viral Vector Production Market
8.7.1 Rest of LAMEA Viral Vector Production Market, by Type
8.7.2 Rest of LAMEA Viral Vector Production Market, by Indication
8.7.3 Rest of LAMEA Viral Vector Production Market, by Application

Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 LAMEA Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 5 LAMEA Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 13 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 16 LAMEA Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 17 LAMEA Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 23 LAMEA Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 26 LAMEA Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 27 LAMEA Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 33 Brazil Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 34 Brazil Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 35 Brazil Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 36 Brazil Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 37 Brazil Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 38 Brazil Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 39 Brazil Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 40 Brazil Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 41 Argentina Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 42 Argentina Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 43 Argentina Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 44 Argentina Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 45 Argentina Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 46 Argentina Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 47 Argentina Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 48 Argentina Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 49 UAE Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 50 UAE Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 51 UAE Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 52 UAE Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 53 UAE Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 54 UAE Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 55 UAE Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 56 UAE Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 65 South Africa Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 66 South Africa Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 67 South Africa Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 68 South Africa Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 69 South Africa Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 70 South Africa Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 71 South Africa Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 72 South Africa Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 73 Nigeria Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 74 Nigeria Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 75 Nigeria Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 76 Nigeria Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 77 Nigeria Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 78 Nigeria Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 79 Nigeria Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 80 Nigeria Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Andelyn Biosciences, Inc.
TABLE 90 key information – Charles River Laboratories International, Inc.
TABLE 91 Key Information – Danaher Corporation
TABLE 92 Key Information – FinVector Oy
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key Information – Novartis AG
TABLE 95 Key Information – Takara Bio Inc.
TABLE 96 Key Information – Avid Bioservices, Inc.
TABLE 97 Key Information – Oxford Biomedica PLC
TABLE 98 Key Information –Lonza Group Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Viral Vector Production Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Viral Vector Production Market
FIG 4 Porter’s Five Forces Analysis – viral vector production market
FIG 5 LAMEA Viral Vector Production Market share, by Type, 2022
FIG 6 LAMEA Viral Vector Production Market share, by Type, 2030
FIG 7 LAMEA Viral Vector Production Market, by Type, 2019 - 2030, USD Million
FIG 8 LAMEA Viral Vector Production Market share, by Indication, 2022
FIG 9 LAMEA Viral Vector Production Market share, by Indication, 2030
FIG 10 LAMEA Viral Vector Production Market, by Indication, 2019 - 2030, USD Million
FIG 11 LAMEA Viral Vector Production Market share, by Application, 2022
FIG 12 LAMEA Viral Vector Production Market share, by Application, 2030
FIG 13 LAMEA Viral Vector Production Market, by Application, 2019 - 2030, USD Million
FIG 14 LAMEA Viral Vector Production Market share, by Country, 2022
FIG 15 LAMEA Viral Vector Production Market share, by Country, 2030
FIG 16 LAMEA Viral Vector Production Market, by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Andelyn Biosciences, Inc.
FIG 18 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 19 Swot Analysis: Charles River Laboratories International, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 22 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Recent strategies and developments: Oxford Biomedica plc
FIG 25 Swot Analysis: Lonza Group Ltd.